New developments in melanoma: Utility of ultrasound imaging (initial staging, follow-up and pre-SLNB)

Expert Review of Anticancer Therapy

Volumn 11, Issue 11, 2011, Pages 1693-1701

  Ulrich, Jens ^a   van Akkooi, Alexander J C ^b   Eggermont, Alexander M M ^c   Voit, Christiane ^d  

^a Department of Dermatology   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; DIAGNOSTIC PROCEDURE; EARLY CANCER; ECHOGRAPHY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MELANOMA; MORPHOLOGY; PRIMARY TUMOR; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; META ANALYSIS (TOPIC); METHODOLOGY; PATHOLOGY;

FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MELANOMA; META-ANALYSIS AS TOPIC; NEOPLASM STAGING;

EID: 84857073004     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.11.115     Document Type: Review

References (72)

1. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann. Oncol. 20(Suppl. 6), vi1-vi7 (2009).
2. de Vries E, Houterman S, Janssen-Heijnen ML et al. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann. Oncol. 18(6), 1110-1116 (2007).
3. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur. J. Cancer 40(16), 2355-2366 (2004).
4. Balch CM, Gershenwald JE, Soong SJ et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27(36), 6199-6206 (2009).
5. Buzzell RA, Zitelli JA. Favorable prognostic factors in recurrent and metastatic melanoma. J. Am. Acad. Dermatol. 34(5 Pt 1), 798-803 (1996).
6. Balch CM, Gershenwald JE, Soong SJ et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J. Clin. Oncol. 28(14), 2452-2459 (2010).
7. Eggermont AM, Suciu S, Santinami M et al. Adjuvant therapy with pegylated interferon a-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised Phase III trial. Lancet 372(9633), 117-126 (2008).
8. Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann. Surg. 214(5), 637-641 (1991).
9. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127(4), 392-399 (1992).
10. Marsden JR, Newton-Bishop JA, Burrows L et al. Revised UK guidelines for the management of cutaneous melanoma 2010. J. Plast. Reconstr. Aesthet. Surg. 63(9), 1401-1419 (2010).
11. Garbe C, Peris K, Hauschild A et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur. J. Cancer 46(2), 270-283 (2010).
12. Morton DL, Thompson JF, Cochran AJ et al. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 355(13), 1307-1317 (2006).
13. Strauss DC, Thomas JM. What does the medical profession mean by ‘standard of care?’ J. Clin. Oncol. 27(32), e192-e193 (2009).
14. Balch CM, Soong SJ, Gershenwald JE et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 19(16), 3622-3634 (2001).
15. Ulrich J, Bonnekoh B, Bockelmann R et al. Prognostic significance of detecting micrometastases by tyrosinase RT/PCR in sentinel lymph node biopsies: lessons from 322 consecutive melanoma patients. Eur. J. Cancer 40(18), 2812-2819 (2004).
16. van Akkooi AC, de Wilt JH, Verhoef C et al. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur. J. Cancer 42(3), 372-380 (2006).
17. Sassen S, Shaw HM, Colman MH, Scolyer RA, Thompson JF. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center. Ann. Surg. Oncol. 15(2), 630-637 (2008).
18. Gershenwald JE, Andtbacka RH, Prieto VG et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J. Clin. Oncol. 10,26(26), 4296-4303 (2008).
19. Cook MG, Green MA, Anderson B et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J. Pathol. 200(3), 314-319 (2003).
20. Veronesi U, Adamus J, Bandiera DC et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N. Engl. J. Med. 297, 627-630 (1977).
21. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 41, 948-956 (1978).
22. Balch CM, Soong SJ, Bartolucci AA et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann. Surg. 224, 255-263 (1996).
23. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351, 793-796 (1998).
24. van Akkooi AC, Nowecki ZI, Voit C et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann. Surg. 248, 949-955 (2008).
25. Wong SL, Morton DL, Thompson JF et al. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann. Surg. Oncol. 13, 809-816 (2006).
26. Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat. Clin. Pract. Oncol. 5, 18-23 (2008).
27. van Akkooi AC, Voit CA, Verhoef C, Eggermont AM. New developments in sentinel node staging in melanoma: controversies and alternatives. Curr. Opin. Oncol. 22, 169-177 (2010).
28. van Akkooi A, de Wilt J, Verhoef C et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann. Oncol. 17, 1578-1585 (2006).
29. Brobeil A, Cruse CW, Messina JL et al. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surg. Oncol. Clin. N. Am. 8, 435-445, viii (1999).
30. Gershenwald JE, Thompson W, Mansfield PF et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J. Clin. Oncol. 17, 976-983 (1999).
31. Ulrich J, Voit C. Ultrasound in dermatology. Part II. Ultrasound of regional lymph node basins and subcutaneous tumours. Eur. J. Dermatol. 11, 73-79 (2001).
32. Schafer-Hesterberg G, Schoengen A, Sterry W, Voit C. Use of ultrasound to early identify, diagnose and localize metastases in melanoma patients. Expert Rev. Anticancer Ther. 7, 1707-1716 (2007).
33. Jemec GB, Gniadecka M, Ulrich J. Ultrasound in dermatology. Part I. High frequency ultrasound. Eur. J. Dermatol. 10, 492-497 (2000).
34. Machet L, Belot V, Naouri M et al. Preoperative measurement of thickness of cutaneous melanoma using high-resolution 20 MHz ultrasound imaging: a monocenter prospective study and systematic review ofthe literature. Ultrasound Med. Biol. 35, 1411-1420 (2009).
35. Ulrich J, Petereit S, Gollnick H. [Preoperative sonographic diagnosis of melanoma - comparison of 7.5- and 20-MHz sonography]. Ultraschall. Med. 20, 197-200 (1999).
36. Vilana R, Puig S, Sanchez M et al. Preoperative assessment of cutaneous melanoma thickness using 10-MHz sonography. AJR Am. J. Roentgenol. 193, 639-643 (2009).
37. Music MM, Hertl K, Kadivec M, Pavlovic MD, Hocevar M. Pre-operative ultrasound with a 12-15 MHz linear probe reliably differentiates between melanoma thicker and thinner than 1 mm. J. Eur. Acad. Dermatol. Venereol. 24, 1105-1108 (2010).
38. Tacke J, Haagen G, Hornstein OP et al. Clinical relevance of sonometry-derived tumour thickness in malignant melanoma - a statistical analysis. Br. J. Dermatol. 132, 209-214 (1995).
39. Klode J, Dissemond J, Grabbe S, Hillen U, Poeppel T, Boeing C. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II. Dermatol. Surg. 36, 439-445 (2010).
40. Xing Y, Bronstein Y, Ross MI et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J. Natl Cancer Inst. 103, 129-142 (2011).
41. Voit C, Proebstle TM, Winter H et al. Presurgical ultrasound-guided anchor-wire marking of soft tissue metastases in stage III melanoma patients. Dermatol. Surg. 27, 129-132 (2001).
42. Testori A, Rastrelli M, De FE et al. Radio-guided ultrasound lymph node localization: feasibility of a new technique for localizing and excising nonpalpable lymph nodes ultrasound suspicious for melanoma metastases. Melanoma Res. 20, 197-202 (2010).
43. Ling A, Dawkins R, Bailey M et al. Short-term morbidity associated with sentinel lymph node biopsy in cutaneous malignant melanoma. Australas. J. Dermatol. 51, 13-17 (2010).
44. Leboulleux S, Girard E, Rose M et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followedup for differentiated thyroid cancer. J. Clin. Endocrinol. Metab 92, 3590-3594 (2007).
45. Cho N, Moon WK, Han W, Park IA, Cho J, Noh DY. Preoperative sonographic classification of axillary lymph nodes in patients with breast cancer: node-to-node correlation with surgical histology and sentinel node biopsy results. AJR Am. J. Roentgenol. 193, 1731-1737 (2009).
46. Kahle B, Hoffend J, Wacker J, Hartschuh W. Preoperative ultrasonographic identification of the sentinel lymph node in patients with malignant melanoma. Cancer 97, 1947-1954 (2003).
47. Bossi MC, Sanvito S, Lovati E, De Fiori E, Testori A, Bellomi M. Role of high resolution color-Doppler US of the sentinel node in patients with stage I melanoma. Radiol. Med. (Torino) 102, 357-362 (2001).
48. Rossi CR, Mocellin S, Scagnet B et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J. Surg. Oncol. 83, 80-84 (2003).
49. Hocevar M, Bracko M, Pogacnik A et al. The role of preoperative ultrasonography in reducing the number of sentinel lymph node procedures in melanoma. Melanoma Res. 14, 533-536 (2004).
50. van Rijk MC, Teertstra HJ, Peterse JL et al. Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann. Surg. Oncol. 13, 1511-1516 (2006).
51. Sanki A, Uren RF, Moncrieff M et al. Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J. Clin. Oncol. 27, 5614-5619 (2009).
52. Starritt EC, Uren RF, Scolyer RA, Quinn MJ, Thompson JF. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann. Surg. Oncol. 12, 18-23 (2005).
53. Prayer L, Winkelbauer H, Gritzmann N, Winkelbauer F, Helmer M, Pehamberger H. Sonography versus palpation in the detection of regional lymph-node metastases in patients with malignant melanoma. Eur. J. Cancer 26, 827-830 (1990).
54. Binder M, Kittler H, Steiner A, Dorffner R, Wolff K, Pehamberger H. Lymph node sonography versus palpation for detecting recurrent disease in patients with malignant melanoma. Eur. J. Cancer 33, 1805-1808 (1997).
55. Rossi CR, Seno A, Vecchiato A et al. The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma. Eur. J. Cancer 33, 200-203 (1997).
56. Blum A, Schlagenhauff B, Stroebel W, Breuninger H, Rassner G, Garbe C. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer 88, 2534-2539 (2000).
57. Voit C, Mayer T, Kron M et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 91, 2409-2416 (2001).
58. Garbe C, Paul A, Kohler-Spath H et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J. Clin. Oncol. 21, 520-529 (2003).
59. Schmid-Wendtner MH, Paerschke G, Baumert J, Plewig G, Volkenandt M. Value of ultrasonography compared with physical examination for the detection of locoregional metastases in patients with cutaneous melanoma. Melanoma Res. 13, 183-188 (2003).
60. Hofmann U, Szedlak M, Rittgen W, Jung EG, Schadendorf D. Primary staging and follow-up in melanoma patients - monocenter evaluation of methods, costs and patient survival. Br. J. Cancer 87, 151-157 (2002).
61. Leiter U, Marghoob AA, Lasithiotakis K et al. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma. Melanoma Res. 19, 50-57 (2009).
62. Bafounta ML, Beauchet A, Chagnon S, Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol. 5, 673-680 (2004).
63. Leiter U, Buettner PG, Eigentler TK, Forschner A, Meier F, Garbe C. Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit? Melanoma Res. 20, 240-246 (2010).
64. Garbe C, Hauschild A, Volkenandt M et al. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res. 17, 393-399 (2007).
65. Voit C, van Akkooi AC, Schafer- Hesterberg G et al. Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J. Clin. Oncol. 28, 847-852 (2010).
66. Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J. Clin. Oncol. 22, 3345-3349 (2004).
67. van der Ploeg AP, van Akkooi AC, Rutkowski P et al. Prognosis in sentinel node-positive melanoma patients is accurately defined by theCombined Rotterdam Tumor Load and Dewar Topography Criteria. J. Clin. Oncol. 29(16), 2206-2214 (2011).
68. Voit CA, van Akkooi AC, Schafer- Hesterberg G et al. Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)- guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J. Clin. Oncol. 27, 4994-5000 (2009).
69. van Akkooi AC, Verhoef C, Eggermont AM. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat. Rev. Clin. Oncol. 7(8), 446-454 (2010).
70. Lam TK, Uren RF, Scolyer RA, Quinn MJ, Shannon KF, Thompson JF. False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res. 19, 94-99 (2009).
71. Schafer-Hesterberg G, Voit C. Ultrasound pre sentinel node dissection. Melanoma Res. 18, 68-69 (2008).
72. Meyers MO, Yeh JJ, Amos KD, Long P, J Frank, Ollila DW. J. Clin. Oncol. 27, 478s (2009) (Abstract 9071) www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=65&abstractID=33288